Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18353371rdf:typepubmed:Citationlld:pubmed
pubmed-article:18353371lifeskim:mentionsumls-concept:C0242422lld:lifeskim
pubmed-article:18353371lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:18353371lifeskim:mentionsumls-concept:C0751072lld:lifeskim
pubmed-article:18353371lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:18353371lifeskim:mentionsumls-concept:C1425650lld:lifeskim
pubmed-article:18353371lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:18353371lifeskim:mentionsumls-concept:C0205549lld:lifeskim
pubmed-article:18353371pubmed:issue1-2lld:pubmed
pubmed-article:18353371pubmed:dateCreated2008-6-9lld:pubmed
pubmed-article:18353371pubmed:abstractTextThe neuropathology associated with LRRK2 mutations is heterogeneous but Lewy body (LB) type pathology is the most common substrate encountered. While the prevalence of LRRK2 mutations has been extensively studied in Parkinson's disease (PD), limited information is available on the frequency of LRRK2 mutations in dementia with Lewy bodies (DLB) and in other pathological conditions associated with these mutations, such as non-specific nigral degeneration without LB, tau-immunopositive neurofibrillary tangle pathology, and ubiquitin-positive neuronal inclusions resembling those observed in a subtype of frontotemporal lobar degeneration (FTLD-U).lld:pubmed
pubmed-article:18353371pubmed:languageenglld:pubmed
pubmed-article:18353371pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18353371pubmed:citationSubsetIMlld:pubmed
pubmed-article:18353371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18353371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18353371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18353371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18353371pubmed:statusMEDLINElld:pubmed
pubmed-article:18353371pubmed:monthJullld:pubmed
pubmed-article:18353371pubmed:issn0022-510Xlld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:ValldeoriolaF...lld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:TolosaEduardo...lld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:MolinuevoJosé...lld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:EzquerraMario...lld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:MuñozEstebanElld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:CardozoAdrian...lld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:ReyMaria...lld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:MartíMaria...lld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:GaigCarlesClld:pubmed
pubmed-article:18353371pubmed:authorpubmed-author:LladóAlbertAlld:pubmed
pubmed-article:18353371pubmed:issnTypePrintlld:pubmed
pubmed-article:18353371pubmed:day15lld:pubmed
pubmed-article:18353371pubmed:volume270lld:pubmed
pubmed-article:18353371pubmed:ownerNLMlld:pubmed
pubmed-article:18353371pubmed:authorsCompleteYlld:pubmed
pubmed-article:18353371pubmed:pagination94-8lld:pubmed
pubmed-article:18353371pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:meshHeadingpubmed-meshheading:18353371...lld:pubmed
pubmed-article:18353371pubmed:year2008lld:pubmed
pubmed-article:18353371pubmed:articleTitleScreening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration.lld:pubmed
pubmed-article:18353371pubmed:affiliationDepartment of Neurology, Hospital Clínic i Universitari de Barcelona, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Barcelona, Spain.lld:pubmed
pubmed-article:18353371pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18353371pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:120892entrezgene:pubmedpubmed-article:18353371lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18353371lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18353371lld:entrezgene
lhgdn:association:23270lhgdn:found_inpubmed-article:18353371lld:lhgdn
lhgdn:association:23327lhgdn:found_inpubmed-article:18353371lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18353371lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18353371lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18353371lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18353371lld:pubmed